AstraZeneca Says BRILINTA Not Yet Approved; Expecting Approval Decision Soon - AstraZeneca (NASDAQ:AZN)

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.

After calling the company to confirm the earlier rumor posted here, a spokesperson for AstraZeneca (NYSE: AZN) says that BRILINTA has not yet received FDA approval. Nevertheless, the company "expects" approval soon, according to the call.AstraZeneca is currently trading at $50/share in post-market trading after rumors of FDA approval circulated. This represents a premium of 1% to its closing price.

27% profits every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!